plantainoside D: antioxidant from the leaves of Picrorhiza scrophulariiflora (Scrophulariaceae); structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Picrorhiza scrophulariiflora | species | [no description available] | Plantaginaceae | A plant family of order Lamiales. The Plantago genus is best known. Lesser known members include Hippuris, Littorella and Callitriche.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 154809630 |
SCHEMBL ID | 23512286 |
MeSH ID | M0506449 |
Synonym |
---|
plantainoside d |
SCHEMBL23512286 |
147331-98-4 |
isoplantamajoside |
3,4-dihydroxyphenethyl 3-o-beta-d-glucopyranosyl-6-o-(3,4-dihydroxycinnamoyl)-beta-d-glucopyranoside |
AKOS040758813 |
Plantainoside D (PD) is a potential anti-hypertensive active ingredient. PD was newly isolated from the dried plants of Chirita longgangensis var.
Excerpt | Reference |
---|---|
"Plantainoside D (PD) is a potential anti-hypertensive active ingredient newly isolated from the dried plants of Chirita longgangensis var. " | ( LC-ESI-MS/MS analysis and pharmacokinetics of plantainoside D isolated from Chirita longgangensis var. hongyao, a potential anti-hypertensive active component in rats. Fu, S; Gong, M; Li, J; Qiu, F; Wang, M; Zhang, X, 2014) |
Excerpt | Reference |
---|---|
" The present method has been applied for pharmacokinetic study of PD after oral and intravenous administration in rats." | ( LC-ESI-MS/MS analysis and pharmacokinetics of plantainoside D isolated from Chirita longgangensis var. hongyao, a potential anti-hypertensive active component in rats. Fu, S; Gong, M; Li, J; Qiu, F; Wang, M; Zhang, X, 2014) |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |